Neratinib
Neratinib is prescribed as an adjuvant therapy to treat adult patients with an early stage HER2 - positive breast cancer who have been already treated with trastuzumab therapy at least for a year.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer
© All Rights Reserved 1997 - 2022
This site complies with the HONcode standard for trustworthy health information: verify here.